Persistent Systems Limited (PERSISTENT) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Persistent Systems enters its Q1 FY27 results following a year of strong deal momentum and a clear currency tailwind that supported its path toward a $2 billion annualized revenue run rate. Investors will be closely watching how the company balances this favorable USD/INR translation against rising H-1B visa costs and the integration of its recent Nagarro acquisition.

Persistent Systems Limited Q1 Results Date and Time

The company has scheduled a board meeting for August 02, 2026, to consider the audited financial results and recommend dividend for FY 2026-2027.

What to expect from Persistent Systems Limited's Q1 FY27 results

Persistent Systems is tracking toward a $2 billion annualized revenue run rate by Q4 FY27, with Q1 serving as the initial benchmark for this trajectory. The company benefits from a sequential USD/INR depreciation of approximately 1.8% during the quarter, which provides a tailwind for reported INR revenue and margin translation. Conversely, the FY2027 H-1B visa season—governed by a new wage-weighted selection process and a $100,000 supplemental fee—creates a material margin headwind that may offset currency gains. Management maintains a 16–17% EBIT margin aspiration for FY27, though reinvestment in AI capabilities and GenAI partnerships remains a primary strategic priority. The upcoming call will likely focus on the integration timeline of the Nagarro acquisition and the sustainability of the $600.8 million TCV recorded in the previous quarter.

Key Things To Watch

Revenue and Margin Dynamics: Tracking the interplay between currency tailwinds and operational costs.

• Quantify the net impact of the 1.8% USD/INR tailwind against H-1B visa cost increases.
• Monitor underlying constant-currency growth to gauge true demand versus reported INR inflation.
• Assess if EBIT margins remain within the 16–17% aspiration given rising visa and wage costs.

Strategic Growth and Acquisitions: Evaluating the path to a $2 billion annualized run rate.

• Update on the Nagarro acquisition integration timeline and its impact on FY27 financial guidance.
• Performance of the AI/GenAI revenue stream given the 500-agent investment base.
• Status of the $2 billion annualized revenue run rate target by Q4 FY27.

Deal Momentum and Vertical Performance: Monitoring the order book following a $2.4 billion FY26 TCV.

• Check if Q1 TCV momentum sustains the $600.8 million level achieved in Q4 FY26.
• Growth trajectory in BFSI and Hi-Tech verticals, which represent 74% of revenue.
• Healthcare vertical recovery following recent optimization cycles.